3种清热解毒类中药注射剂的药学监护

doi:10.19803/j.1672-8629.2022.04.21

摘要/Abstract

摘要： 目的为临床合理使用喜炎平、痰热清、热毒宁3种解热解毒类中药注射剂用药提供参考。方法通过对喜炎平、痰热清、热毒宁在临床应用中存在的问题及需要临床药师监护的内容进行分析总结。结果喜炎平、痰热清、热毒宁药品说明书对中医病、证的描述不全,在临床使用存在辨证不准确、溶媒选择不当、超西医适应证等方面的问题。结论临床药师可以从用药指征、用法用量、配伍禁忌、不良反应等方面加强清热解毒类中药注射剂的药学监护,以保障临床用药安全、有效、合理。

关键词: 喜炎平, 痰热清, 热毒宁, 药学监护, 中药注射剂, 清热解毒

Abstract: Objective To provide evidence-based data for the rational use of three types of antipyretic and antidotal injections: Xiyanping, Tanreqing and Reduning. Methods The problems with clinical use of Xiyanping, Tanreqing and Reduning were summarized and analyzed. Results The instructions about Xiyanping, Tanreqing and Reduning failed to give a detailed account of the diseases and syndromes diagnosed by TCM. There were problems with clinical use of these drugs, such as inaccurate syndrome differentiation, improper solvent selection and use of these drugs beyond indications specified by western medicine. Conclusion Clinical pharmacists can strengthen the pharmaceutical care of the three drugs in terms of medication indications, usage and dosage, incompatibility and adverse reactions so as to ensure safe, effective and rational medication.

Key words: Xiyanping injection, Tanreqing injection, Reduning injection, pharmaceutical care, traditional Chinese medicine injections, Qinrejiedu

中图分类号:

R994.11

周鹏, 杨晶晶. 3种清热解毒类中药注射剂的药学监护[J]. 中国药物警戒, 2022, 19(4): 441-445.

ZHOU Peng, YANG Jingjing. Pharmaceutical care of three types of Qingrejiedu traditional Chinese medicine injections[J]. Chinese Journal of Pharmacovigilance, 2022, 19(4): 441-445.

参考文献

[1] Center for Drug Reevaluation, NMPA. National Center for ADR Monitoring, China[EB/OL].(2020-04-10)[2020-05-20]. https://www.cdr-adr.org.cn/tzgg_home/202004/t20200410_47300.html.
[2] ZHANG J, MA J, LI XL.Discussion on syndrome differentiation and disease differentiation of Chinese patent medicine[J]. China Pharm(中国药房), 2011, 22(39): 3649-3650.
[3] CHEN P.Analysis of the application of Xiyanping Injection[J].Modern Preventive Medicine(现代预防医学), 2010, 37(15): 3000-3001.
[4] LI XX, YIN J, ZHU HR, et al.Evalution on the prescription patterns of Tanreqing injection based on a real world study[J]. Chin Hosp Pharm J(中国医院药学杂志), 2019, 39(23): 2412-2416.
[5] WANG LX, YANG W, XIE YM, et al.Real-world clinical application and safety analysis of Xiyanping injection in 4023 patients[J]. Journal of Traditional Chinese Medicine(中医杂志), 2014, 55(7): 571-575.
[6] ZHENG QX, YE H.Observation on syndrome differentiation of reduning injection in treating exogenous fever[J]. Clinical Rational Drug Use(临床合理用药), 2013, 6(4C): 76-77.
[7] DANG Y, SHI JP, LAN DD, et al.Comparative study of syndrome differentiation and precision medicine under the combination of disease and syndrome[J]. CJTCMP(中华中医药杂志), 2019, 34(12): 5615-5617.
[8] Chinese Society of Traditional Chinese medicine, Chinese Society of Traditional Chinese Medicine Lung Diseases, Lung Disease Branch of Chinese National Medical Association. Chinese medical diagnostic and treatment guidelines for community-acquired pneumonia (2018 revision)[J]. Chinese Journal of Traditional Chinese medicine(中医杂志), 2019, 60(4): 350-359.
[9] Committee of Pulmonary Diseases, Internal Medicine Branch, Chinese Medical Association. Chinese medical diagnostic and therapeutic guidelines for chronic obstructive pulmonary disease (2011 edition)[J]. Chinese Journal of Traditional Chinese medicine(中医杂志), 2012, 53(1): 80-84.
[10] HAO WD, WANG GF.Efficacy of Xiyanping combined with bipap non-invasive ventilation in treatment of AECOPD with syndrome of phlegm-heat obstructing lung complicated with respiratory failure and pneumonia and effects on PCT,strem-1 and quality of life[J], Chinese Journal of Experimental Traditional Medical Formulae(中国实验方剂学杂志), 2017, 23(14): 193-197.
[11] DONG HZ, ZHANG W.The Clinical curative effect of reduning injection on treating acute exacerbation of chronic obstructive pulmonary disease syndrome of phlegm heat obstructing in the lung[J]. JETCM(中国中医急症), 2015, 24(8): 1433-1435.
[12] ZHAO Y, SHI S, Huang P.Analysis of clinical use of post-marketing hospital centralized monitoring of Xiyanping injection[J]. Chin J Chin Mater Med(中国中药杂志), 2016, 41(4): 743-747.
[13] MENG F, LI XL.Discussion on Chinese medicine proprietary speciﬁ- cation term representation method[J]. Clinical Journal of Traditional Chinese Medicine(中医药临床杂志), 2015, 27(1): 111-112.
[14] ZHANG YY.Application of Reduning Injection in clinical treat-ment[J]. Strait Pharmaceutical Journal(海峡药学), 2017, 29(6): 128-130.
[15] LIU WL, ZHANG XW, ZHANG B.Clinical analysis of 120 cases of incompatibility of Xiyanping injection with different drug[J]. China Pharmaceuticals(中国药业), 2017, 26(22): 84-85.
[16] DU R, YUAN H, YU X.Stability of Reduning,Tanreqing and Xiyanping Injections in clinical use[J]. Chin Hosp Pharm J(中国医院药学杂志), 2016, 36(13): 1095-1099.
[17] WANG ZF, ZHANG HR, XIE HM, et al.Expert consensus statement on Xiyanping Injection for respiratory systeminfectious diseases in clinical practice (adults)[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2019, 44(24): 5282-5286.
[18] LI GB, TANG QP, YANG QZ.Stability of Reduning injection and its compatibility with cephalosporins[J]. Chinese Journal of Medical Guidance(中国医药指南), 2013, 11(30): 47-49.
[19] XI SH.Study on the incompatibility and prevention of Tanreqing injection and other drugs[J]. Everyone's health (Academic)(大家健康(学术版)), 2013, 7(24): 156.
[20] LI YH, DU JS, XU T.Discussion on the key points of clinical pharmaceutical care based on the interaction between Chinese and western medicine[J]. Chinese Traditional Patent Medicine(中成药), 2016, 38(1): 222-226.
[21] HOU CS, YANG ZH, SUN XB."Cocktail" probe drug method and its application in the study of the effect of traditional Chinese medicine on cytochrome P450[J]. Chin J Pharmacol Toxicol(中国药理学与毒理学杂志), 2013, 27(3): 445-450.
[22] LIU Q, LIU KX.Advances in the study of enzymes and transporters-mediated pharmacokinetic mechanism for herb-drug interaction[J].Acta Pharmaceutica Sinica(药学学报), 2015, 50(4): 406-412.
[23] LIN Q, ZHANG S.Analysis of 270 cases of adverse drug reactions/events reports caused by Xiyanping injection[J]. Chinese Journal of Pharmacovigilance(中国药物警戒),2012, 9(12): 751-754.
[24] YANG XM.Microparticle observation of Tanreqing injection combined with infusion[J]. Chinese Traditional Patent Medicine(中成药), 2006, 28(3): 462-463.
[25] WANG YX, LIU T, WANG ZZ,et al.Study on the compatible stability of Reduning injection and solvent[J]. Chin J Chin Mater Med(中国中药杂志), 2010, 35(22): 2990-2992.
[26] ZHANG GP, GAO YH, SU P, et al.Development and prospect of liquid preparation of traditional Chinese medicine for lung inhala-tion[J]. Mod Chin Med(中国现代中药), 2019, 21(12): 1732-1738.
[27] Chinese Society of Clinical Pharmacy "Consensus of experts on rational drug use in aerosol inhalation therapy" Writing Group. Consensus of experts on rational drug use in aerosol inhalation therapy(2019)[J]. Herald of Medicine(医药导报), 2019, 38(2): 135-146.
[28] GENG L, FANG BX, CHEN SM, et al.Meta-analysis of different administrative route of Xiyanping injection for treating respiratory tract infection in children[J]. Modern Journal of Integrated Traditional Chinese and Western Medicine(现代中西医结合杂志), 2014, 23(29): 3214.
[29] ZHANG TW.Clinical observation on curative effects of aerobic inhalation of Redu'ning on acute upper respiratory tract infection in children[J]. Clinical Journal of Chinese Medicine(中医临床研究), 2017, 9(34): 61-63.
[30] YU L, QIU SJ, TAN XY.Analysis of 110 cases of adverse drug reactions induced by Tanreqing injection[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2015, 12(6): 360-362.